Home > Drug Search >
  • company_query: Apeiron Biologics
  •   > 
Drug Filter
Category:
chemistry (5) biology (19)
Status:
Approved (1) Phase Ⅲ (2) Phase Ⅱ (15) Phase Ⅰ (6)
Clinical Stage:
Pending (3) Active (17) Discontinued (3)
Bio-Type:
Gene therapy (2) CAR T cell therapy (7) Vaccine (1) Recombinant enzyme (2) Whole antibody (5) Fusion protein (2)
Indication:
Acute lymphoblastic leukaemia (ALL) (3) Alzheimer's disease (AD) (1) Chronic lymphocytic leukemia (CLL) (1) Chronic myeloid leukemia (CML ) (1) Pigmented villonodular synovitis (1) Gastric cancer (1) Leukemia (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (3) Non-Hodgkin’s lymphoma (NHL) (1) Osteoarthritis (OA) (1) Ovarian cancer (3) Prostate cancer (2) Psoriasis (1) Peyronie's disease (1) Rheumatoid arthritis (RA) (1) Solid tumours (2) Radiodermatitis (1) Nosocomial Pneumonia (NP) (1) Neuroblastoma (3) Acute Lung Injury (1) Hematological cancer (1) Peritoneum cancer (1) Staphylococcal infection (2) Mesothelioma (2) Respiratory distress syndrome (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top